Financial News
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
March 02, 2023 at 05:59 AM EST
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
--News Direct--
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing the data readout from an LPS human challenge trial for POLB 001, the infectious disease focused biopharma company's lead molecule.
Skillington says that he "couldn't be happier" with the results, that he says will help "ramp up the discussions" with potential partners.
Contact Details
Proactive UK Ltd
+44 20 7989 0813
View source version on newsdirect.com: https://newsdirect.com/news/poolbeg-pharma-couldnt-be-happier-with-polb-001-human-challenge-trial-data-264590133
Report this content
If you believe this article contains misleading, harmful, or spam content, please let us know.
Report this articleMore News
View More
Stride Q4 Earnings Call Highlights ↗
Today 5:04 EDT
Lumen Technologies Q2 Earnings Call Highlights ↗
Today 5:04 EDT
Macerich Q2 Earnings Call Highlights ↗
Today 5:04 EDT
Chunghwa Telecom Q2 Earnings Call Highlights ↗
Today 5:04 EDT
loanDepot Q2 Earnings Call Highlights ↗
Today 5:04 EDT
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
